Anti-B cell strategy for complicated steroid-dependent nephrotic syndrome in children with antirituximab antibodies
- PMID: 35585367
- DOI: 10.1007/s00467-022-05612-3
Anti-B cell strategy for complicated steroid-dependent nephrotic syndrome in children with antirituximab antibodies
Comment on
-
Anti-rituximab antibodies in pediatric steroid-dependent nephrotic syndrome.Pediatr Nephrol. 2022 Feb;37(2):357-365. doi: 10.1007/s00467-021-05069-w. Epub 2021 Jun 16. Pediatr Nephrol. 2022. PMID: 34132894
References
-
- Bertrand Q, Mignot S, Kwon T, Couderc A, Maisin A, Cambier A, Baudouin V, Peyneau M, Deschênes G, Hogan J, Dossier C (2022) Anti-rituximab antibodies in pediatric steroid-dependent nephrotic syndrome. Pediatr Nephrol 37:357–365 - PubMed
-
- Fujinaga S, Nishino T, Endo S, Umeda C, Watanabe Y, Nakagawa M (2020) Unfavorable impact of anti-rituximab antibodies on clinical outcomes in children with complicated steroid-dependent nephrotic syndrome. Pediatr Nephrol 35:2003–2008 - PubMed
-
- Ravani P, Colucci M, Bruschi M, Vivarelli M, Cioni M, DiDonato A, Cravedi P, Lugani F, Antonini F, Prunotto M, Emma F, Angeletti A, Ghiggeri GM (2021) Human or chimeric monoclonal anti-CD20 antibodies for children with nephrotic syndrome: a superiority randomized trial. J Am Soc Nephrol 32:2652–2663 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
